Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety

O. V. Boyko, Pavel Yakovlev, A. V. Zinkina-Orikhan, Yu. N. Linkova, Roman Ivanov

S S Korsakov Journal of Neurology and Psychiatry · 2019 · 11 citations · 3 references

Concepts

Abstract

Boyko OV, Boyko AN, Yakovlev PA, Zinkina-Orikhan AV, Kotov SV, Lin’kova YuN, Prakhova LN, Totolyan NA, Shchur SG, Ivanov RA. Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety. S.S. Korsakov Journal of Neurology and Psychiatry.

References

3